Company Filing History:
Years Active: 2023
Title: Manuel Ángel González De La Pena: Innovator in Stem Cell Therapy
Introduction
Manuel Ángel González De La Pena is a notable inventor based in Tres Cantos, Madrid, Spain. He has made significant contributions to the field of medical science, particularly in the area of stem cell therapy. His innovative work focuses on utilizing adipose tissue-derived stromal stem cells for therapeutic applications.
Latest Patents
Manuel holds a patent for the "Use of adipose tissue-derived stromal stem cells in treating fistula." This patent outlines novel methods and compositions that leverage these stem cells to effectively treat fistulae. His research represents a promising advancement in regenerative medicine.
Career Highlights
Manuel is currently associated with Takeda Pharmaceutical Company Limited, where he continues to explore and develop innovative medical solutions. His work is characterized by a commitment to improving patient outcomes through scientific research and application.
Collaborations
He collaborates with esteemed colleagues, including María Gema Fernández Miguel and Rosa Ana García Castro, who contribute to his research endeavors and help advance the field of stem cell therapy.
Conclusion
Manuel Ángel González De La Pena is a pioneering inventor whose work in stem cell therapy has the potential to transform treatment options for patients with fistulae. His contributions to medical science are invaluable and highlight the importance of innovation in healthcare.